Vectors for transfer of the gene for thymidine kinase data

Interim results of GTII's brain tumor trial showed that five of eight patients, who all had failed conventional therapies, had measurable antitumor response with the gene therapy. Three of the five patients showing a positive response

Read the full 360 word article

How to gain access

Continue reading with a
two-week free trial.